Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis.
Shigekazu KitamuraTakao TakeshimaDaishi YuiGabriel Paiva da Silva LimaReija KoukakisCheng PengRyuji YoshidaYotaro NumachiMiki HasebePublished in: Neurology and therapy (2023)
In Japanese patients with different migraine frequencies, erenumab treatment resulted in significant improvements in MMD, MSMD, and headache impact. This pooled analysis of data from phase 2 and 3 studies increases confidence that erenumab is efficacious in patients with high MMD, which is associated with increased disability.